Oncolyze, Inc. | Valuation, Funding Rounds & Stock Price | Caplight
Oncolyze, Inc.
Private
New York City, New York
Healthcare & Life Sciences https://oncolyze.com/
Last Round
Series A
Aug 4, 2022
Est. Valuation
$30M
Total Funding Raised
$300,000
Company Overview
Oncolyze, Inc. is a biotechnology company developing novel biotherapeutics for the treatment of cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
biotechnology, drug discovery, oncology, peptide therapeutics, biotech, targeted therapy, preclinical research, drug development, investigational new drug (IND), orphan drug, biopharma, therapeutic pipeline, drug licensing
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Unlock Pricing Charts
Caplight Momentum Score
Proprietary index based on bid/ask volume and sentiment.
View Momentum History
Oncolyze, Inc. Comparables
Compare Oncolyze, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| A28 Therapeutics | 79% | - |
| Peptomyc | 78% | - |
| Lytix Biopharma AS | 73% | - |
| Comparable company | 50% | - |
Oncolyze, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Aug 4, 2022 | - | - | - | - |
| Seed | Jan 1, 2019 | - | - | - | - |
Key People
Founding team and executive leadership
Steve Evans
CEO and Acting Chair
LinkedIn profileAlex Stojanovic
Fractional COO
LinkedIn profile
Oncolyze, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The Naissos Group | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
Apr 16, 2026
Monthly visitors increased 113% MoM.Aug 4, 2022
Closed Series A round at $30M post-money valuation.
Oncolyze, Inc. Filings
SEC and related filings with document metadata.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages |
|---|---|---|---|---|---|
| Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view |
Frequently Asked Questions
Common questions about Oncolyze, Inc.'s valuation, stock price, and market status.
- Is Oncolyze, Inc. a public or private company?
- What is the current stock price of Oncolyze, Inc.?
- How much is Oncolyze, Inc. worth (valuation)?
- Can I buy Oncolyze, Inc. stock?
- When was Oncolyze, Inc.'s last funding round?
- Who are the main investors in Oncolyze, Inc.?
- Will Oncolyze, Inc. IPO soon?
- How can I track Oncolyze, Inc. secondary market activity?
Firmographic Details
- Headquarters: New York City, New York
- Employee Range: 5
- Year Founded: 2011
- Last Funding: Aug 4, 2022